Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Clearside Biomedical, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 53 | 54 | +1 |
| Shares | 13.7M | 12.1M | −1.63M (−11.9%) |
| Value | $20.1M | $13.6M | −$6.49M (−32.2%) |
New holders (7)
Institutions that held Clearside Biomedical, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lincoln National Corp | 92,300 | $104.0K | 0.00% |
| Newman Dignan & Sheerar, Inc. | 27,023 | $31.0K | 0.01% |
| Balyasny Asset Management LLC | 22,443 | $25.0K | 0.00% |
| FMR LLC | 1,100 | $1.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 563 | $1.00K | 0.00% |
| Royal Bank of Canada | 262 | $0 | 0.00% |
| Federated Hermes, Inc. | 69 | – | – |
Sold out (6)
Institutions that held Clearside Biomedical, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Gsa Capital Partners LLP | 98,097 | $144.0K |
| Algert Global LLC | 19,300 | $28.0K |
| Citadel Advisors LLC | 15,266 | $23.0K |
| Integrated Advisors Network LLC | 15,700 | $23.0K |
| ExodusPoint Capital Management, LP | 12,780 | $19.0K |
| Captrust Financial Advisors | 4,400 | $6.00K |